rdf:type |
|
lifeskim:mentions |
umls-concept:C0014939,
umls-concept:C0033268,
umls-concept:C0034786,
umls-concept:C0086418,
umls-concept:C0138741,
umls-concept:C0205263,
umls-concept:C0332206,
umls-concept:C0334227,
umls-concept:C0376358,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1514485
|
pubmed:issue |
11
|
pubmed:dateCreated |
2007-6-27
|
pubmed:abstractText |
Dehydroepiandrosterone (DHEA) is an endogenous steroid that is metabolized to androgens and/or estrogens in the human prostate. DHEA levels decline with age, and use of DHEA supplements to retard the aging process is of unproved effectiveness and safety. LNCaP and LAPC-4 prostate cancer cells were used to determine whether DHEA-modulated proliferation and prostate specific antigen (PSA) production were mediated via the androgen receptor (AR) and/or ERbeta.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Anilides,
http://linkedlifedata.com/resource/pubmed/chemical/Dehydroepiandrosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide,
http://linkedlifedata.com/resource/pubmed/chemical/dehydrotestosterone,
http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0270-4137
|
pubmed:author |
|
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1152-62
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17503469-Androgen Antagonists,
pubmed-meshheading:17503469-Androgen Receptor Antagonists,
pubmed-meshheading:17503469-Anilides,
pubmed-meshheading:17503469-Cell Division,
pubmed-meshheading:17503469-Cell Line, Tumor,
pubmed-meshheading:17503469-Dehydroepiandrosterone,
pubmed-meshheading:17503469-Estradiol,
pubmed-meshheading:17503469-Estrogen Antagonists,
pubmed-meshheading:17503469-Estrogen Receptor beta,
pubmed-meshheading:17503469-Gene Expression,
pubmed-meshheading:17503469-Humans,
pubmed-meshheading:17503469-Male,
pubmed-meshheading:17503469-Nitriles,
pubmed-meshheading:17503469-Prostate-Specific Antigen,
pubmed-meshheading:17503469-Prostatic Neoplasms,
pubmed-meshheading:17503469-RNA, Messenger,
pubmed-meshheading:17503469-RNA, Small Interfering,
pubmed-meshheading:17503469-Receptors, Androgen,
pubmed-meshheading:17503469-Testosterone,
pubmed-meshheading:17503469-Tosyl Compounds
|
pubmed:year |
2007
|
pubmed:articleTitle |
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
|
pubmed:affiliation |
Endocrine Section, Laboratory of Clinical Investigation, Division of Intramural Research, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland 20892-0933, USA. jarnold@mail.nih.gov
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|